Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational study of mycophenolic acid exposure monitoring in heart and lung transplant recipients
2007-002201-53Phase 4Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mycophenolate sodium and mycophenolate mofetil in graft rejection (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoints: Serum mycophenolic acid levels, Salivary mycophenolic acid levels and 3 more. Started Jun 2007; status: completed.
02
Drugs
mycophenolate sodiummycophenolate mofetil
03
Conditions
graft rejection
Beyond the preview
Go deeper on 2007-002201-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002201-53.